Impact of diabetes mellitus on long-term survival in patients with congestive heart failure
Abstract
AIMS: To test the hypothesis that diabetic status may be used as a prognostic indicator in heart failure (HF) patients. METHODS AND RESULTS: We studied 1246 consecutive patients with left ventricular dysfunction. All patients had a cardiopulmonary exercise test and an echocardiogram. Cardiac catheterisation was systematically performed to define HF aetiology. Twenty-two percent of the patients were diabetic (hypoglycaemic drugs or fasting blood glucose >126 mg/dL); in diabetic patients, HF aetiology was ischaemic in 58% vs. 40% in non-diabetic patients ( p < 0.0001). Clinical follow-up (median 1200 days) was obtained for 1241 patients. There was a statistically significant effect of diabetes mellitus on cardiac survival that differed according to HF aetiology (interaction p > 0.01). Diabetes mellitus was an independent predictor of cardiovascular mortality in ischaemic patients (HR=1.54 [1.13; 2.09]; P = 0.006) but not in non-ischaemic patients (HR=0.65 [0.39; 1.07];p = 0.09). When diabetic patients were defined as patients receiving hypoglycaemic drugs at baseline, diabetes mellitus remained an independent predictor of cardiovascular mortality in ischaemic patients (HR=1.43 [1.03; 1.98]; p = 0.03) while diabetes mellitus was associated with a statistically significant decrease in cardiovascular mortality in non-ischaemic patients (HR=0.46 [0.23; 0.88]; p = 0.02). CONCLUSION: The prognostic impact of diabetes mellitus in HF patients is markedly influenced by the underlying aetiology and is particularly deleterious in those with ischaemic cardiomyopathy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The majority of the available data suggests that T2DM is associated with higher risk of mortality in both patients of ischaemic and non-ischaemic aetiology.
“The majority of the available data suggests that T2DM is associated with higher risk of mortality in both patients of ischaemic and non-ischaemic aetiology (Table 6).29,88,94,96 -99”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [97]
Two smaller population-based studies in the United States and France and one Spanish single-centre study suggested that diabetes was only associated with higher mortality in those with non-ischaemic aetiology.
“These consistent findings conflict with two smaller population-based studies in the United States 29 and France 97 and one Spanish single-centre study 101 of patients hospitalized with HF, which suggested that diabetes was only associated with higher mortality in those with non-ischaemic aetiology.”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [97]
The citation lists haven’t been fetched yet
References 22 · Cited by 192
- Authors
- de Groote, P.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04
- Volume
- 25
- Issue
- 8
- Pages
- 656-662
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2142039951
- Cited by
- 192
- References
- 22
- Citations by year
- 2025: 3 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 12 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 9 · 2015: 10 · 2014: 9 · 2013: 7 · 2012: 7
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes mellitus, congestive heart failure, long-term survival, cardiovascular mortality, prognostic factors, heart failure etiology, ischemic cardiomyopathy, left ventricular dysfunction, hypoglycaemic drugs, non-ischemic heart failure
- MeSH terms
- Diabetic Angiopathies, Female, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Netherlands, Prognosis, Survival Rate, Multivariate Analysis, Proportional Hazards Models, Survival Analysis, Myocardial Ischemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review